We invest across Europe in early-stage biopharma companies
Biotech-focused fund backed by the
European Investment Fund and other
public and private investors.
Fund I
57M€
Enhancing
transformative
treatments
Biovance Capital works closely with entrepeneurs to build leading companies with transformative treatments for patients in need. We invest in seed and Series A rounds and typically bring additional investors to add value and mitigate risk.
We grow
stronger,
together
We have developed a wide network across Europe that includes research institutes, incubators and accelerators. Through this network, we have access to a rich pipeline of potential investments.
What our team members have to say
João Incio
At Biovance, we believe the future of medicine lies in the hands of visionary scientists and groundbreaking innovations. Our mission is to empower pioneers with the resources to transform lives and redefine the boundaries of what’s possible.
Ricardo Perdigão Henriques
As the first-ever biotech dedicated fund, Biovance Capital Fund I marks a significant milestone in the development of Portugal's biomedical ecosystem. We are thrilled to launch this fund and support innovative biotech companies across Europe. We are deeply grateful to our investors for their trust and ongoing support.
André Albergaria
With over twenty years fostering collaborations between industry and academia in Portugal's largest health research institute, I am thrilled to contribute to propel exceptional biomedical research from Europe onto the global stage.
